As its processes become more efficient and the company ramps up production, Pfizer expects to slash the production time for each COVID-19 vaccine batch from 110 days to about 60 days on average. The boost in production capacity may help relieve bottlenecks as a result of vaccine shortages.
Sign up for AIChE SmartBrief
News for chemical engineers
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.